Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet signs an agreement with Sponda Ltd on the renting of a new office building to be designed and constructed in Tikkurila, Vantaa

Valmet Oyj’s press release on May 9, 2022 at 10:00 a.m. EESTValmet has signed an agreement with the property investment company Sponda Ltd on the renting of a new office building that will be designed and constructed in Tikkurila, Vantaa in Finland. The office building will be located in the immediate vicinity of the Tikkurila station at the address Lauri Korpisen katu 9. Valmet’s rented floor area in the building will be approximately 13,000 floor square meters. Construction of the development project is scheduled to start this year, and the work is estimated to be completed by the end of

Mourning the loss of Curt Bergfors

It is with great sadness we share that Curt Bergfors, founder of MAX, principal owner and working Chairman of the Board, has passed away on May 8, 2022. He leaves behind his wife, four children, grandchildren, as well as relatives and friends. Curt was a visionary with a wealth of ideas and knowledge, something that has characterized MAX’s development and growth throughout the entire history of the company. His commitment to societal issues and sustainability has also had great impact far beyond the company and the country of Sweden.  - Curt was a beloved husband, father,

Aqilion strengthens its pipeline with a drug candidate in chronic inflammatory bowel diseases, IBD

Aqilion has nominated Girtab, a program from the company’s research activities, for further preclinical and clinical development. The goal of Girtab is to develop a new treatment for chronic inflammatory bowel diseases. Girtab complements Aqilion’s pipeline well and strengthens the company’s strategic focus on drug targets and programs with great potential in inflammatory diseases. The development of Girtab has come so far that there is now a clinical drug candidate, AQ312, to be tested in safety studies in a preclinical development program. In parallel, the development of a dosage form

K-Fastigheter obtains building rights for 130 rental apartments in Höganäs

K-Fastigheter has entered into an agreement with SBB on the acquisition of the subsidiary that owns part of properties Olympia 14 and Stataren 2 in Höganäs. K-Fastigheter plans to build approximately 130 rental apartments in the Group’s proprietary concept buildings Apartment Block and Lateral Low-Rise in Höganäs.K-Fast Holding AB (“K-Fastigheter”) acquires parts of two properties in Höganäs and divests properties in Kristianstad and Hässleholm through a joint venture transaction with SBB. The transaction involves K-Fastigheter acquiring companies owning part of Olympia 14 and part of

Realheart is recruiting Lead Systems Engineer

Press release, 9 May 2022 Realheart has recruited a Lead Systems Engineer from Texas. Bruce Wedding most recently came from a role as a senior software engineer at LivaNova, PLC. Bruce will start working for Realheart on May 9, at the same time as he plans to move himself and his family to the head office in Västerås.Now Realheart strengthens the product development team with Bruce Wedding, who has over 30 years of diverse software engineering and project management experience. In his current role, he is the team leader in the development of a Class III implantable medical device. Bruce

Coor’s climate goals approved by Science Based Targets

Coor’s climate goals have been validated by the Science Based Targets Initiative (SBTi).  In order to limit global warming to 1.5°C, Coor has set a target of reducing its emissions of greenhouse gases under scope 1 and scope 2 by 75% by 2030. To address scope 3, Coor has set a target to ensure that 75% of the company’s scope 3 emissions come from suppliers with targets approved by SBTi.Coor’s overall goal is to develop the business in the best way and maximize financial returns while at the same time helping to build a better future for humans and the environment.   “The fact that our

AcouSort selected by EIC for participation in leading medical exhibition

AcouSort has been selected by the European Innovation Council (EIC) for participation in the European Pavilion at BIO2022 after a highly competitive evaluation process. AcouSort is thus one of 20 European companies selected by EU for full sponsorship at America’s leading medical exhibition, taking place in San Diego June 13-16.– It is of course incredibly inspiring to be one of the 20 European SMEs or startups selected by EIC for participation at BIO2022. We see this as one of the most important conferences in the healthcare and biotech industry, where most leading companies are represented,

DSRT: Desert Control appoints Head of Group Marketing and Communications

ISSUER DESERT CONTROL AS Sandnes, Norway, 09 May 2022Norwegian AgTech company Desert Control has developed a liquid natural clay(LNC) that restores soil and reduces water usage for agriculture and greenlandscapes. The company is now entering the commercial stage in the Middle Eastand is further launching validation initiatives and pilots in the United States.Desert Control strengthens its leadership team with a Head of Group Marketingand Communications to accelerate commercialization, develop its outreachstrategy and elevate global awareness.Desert Control appoints

Cereno Scientific to present candidate drug CS585 preclinical data at EHA 2022 – the premier medical congress for hematology

Cereno Scientific (XSAT: CRNO B) today announced that an abstract on preclinical drug candidate CS585 has been accepted as an oral presentation by the Scientific Program Committee at the European Hematology Association (EHA) 2022 Hybrid Congress in Vienna, Austria, on June 9-12, 2022. The abstract: “CS585 is a first-in-class compound targeting the IP receptor for prevention of thrombosis without increased risk of bleeding” will be presented by Dr. Michael Holinstat, lead of Cereno’s preclinical development programs at University of Michigan and Director of Translational Research at Cereno.“

Invitation to Noreco First Quarter 2022 Earnings Call

Oslo, 9 May 2022: Norwegian Energy Company ASA ("Noreco" or "the Company") will publish its financial results for the first quarter of 2022 on Tuesday 10 May 2022 at 07:00 (CEST).   An earnings call, available as a webcast, will be hosted at 11:00 (CEST). To join webcast:  https://channel.r oyalcast.com/landingpage/hegnarmedia/20220510_10/  ***  Contact: Cathrine Torgersen, EVP Investor Relations & ESG Email: ct@noreco.com Phone: +47

Caverion Corporation’s financial reporting and Annual General Meeting in 2023

Caverion Corporation Stock exchange release 9 May 2022 at 9.20 a.m. EESTCaverion Corporation’s financial reporting and Annual General Meeting in 2023 Caverion will publish its Financial Statements Release for 2022 on Thursday 9 February 2023 at approximately 8:00 a.m. Finnish time (EET). Annual Review 2022 including the financial statements will be published during week 9/2023, at the latest. In addition, Caverion will publish three financial reports in 2023: Interim report for January−March on 27 April 2023Half yearly report for January−June on 3 August 2023Interim report for

Changes in Caverion’s Group Management Board: Mikko Kettunen appointed as CFO

Caverion Corporation Stock exchange release 9 May 2022 at 9.10 a.m. EESTChanges in Caverion’s Group Management Board: Mikko Kettunen appointed as CFO Mikko Kettunen (45), M.Sc. (Econ.), has been appointed as CFO of Caverion Group and a member of the Group Management Board of Caverion Corporation as of 8 November 2022 at the latest. He will report to Jacob Götzsche, President and CEO. Mikko Kettunen’s latest position has been the CFO of the Finnish stock-listed composite solutions manufacturer Exel Composites Plc, where he has also acted earlier in a combined role as CFO and Business

Ted Fjällman new board member at XNK Therapeutics

XNK Therapeutics AB (“XNK”) today announced that Ted Fjällman, Partner at Flerie Invest, has joined the company’s board of directors.Ted Fjällman is Partner at Flerie Invest, a European biotech and pharma investor managing a portfolio of more than 25 companies in the US, UK, Sweden, the Netherlands and other countries. Ted has been CEO and board member of several biotech companies engaged in a wide range of areas including immunology, oncology and biologics development and manufacturing. He holds a Ph.D. in Biotechnology and Immunology from the University of Guelph, Canada, and splits his

Akobo Minerals reaches fundamental milestone on the way to gold production

Akobo Minerals (Euronext Oslo – “AKOBO”), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced that it has reached an agreement with the South African company Solo Resources (Pty) Ltd for delivery of a processing plant for production of gold at the Segele Mine.· Commissioning expected to start by end of first quarter 2023 · The plant will be tailored to process the highly gold rich Segele Mine ore with an Inferred and Indicated Mineral Resource Estimate of 69 kOz gold @22.7 grams per tonne · The plant is designed to process 10 tons of mass per

Krister Zackari appointed Managing Director of Fazer Lifestyle Foods

Krister Zackari has been appointed Managing Director of Fazer Lifestyle Foods and member of the Fazer Leadership Team. Krister joins Fazer from Norrmejerier – Sweden’s 3rd largest dairy company – where he has held the position of CEO since 2021. He will assume his new position at Fazer on 1 July 2022.Krister Zackari has a strong background from various FMCG companies and geographies with more than 25 years’ experience in international business. Prior to his current position, he has held several senior executive and leadership positions, such as Managing Director of Kraft Foods / Mondelēz

Mol Cancer Ther Publishes Bexmarilimab Research

Faron Pharmaceuticals Ltd. (“Faron” or “Company”)   Molecular Cancer Therapeutics Publishes Research on the Nonclinical Characterization of Bexmarilimab   Press release, May 9, 2022 at 02:00 AM (EDT) / 07:00 AM (BST) / 09:00 AM (EEST)   TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that the American Association for Cancer Research (AACR)

SBB sells building rights and acquires community service properties

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) sells building rights for residential properties in Höganäs to K-Fast Holding AB (publ) (“K-Fastigheter”) for a total of approximately SEK 50 million. The building rights are created within SBB's existing residential properties. Closing will take place when  the zooning plan becomes legally binding. SBB also acquires two preschools in Kristianstad and an LSS property (a home for persons with certain functional impairments) in Hässleholm from K-Fastigheter for SEK 50.8 million. The total remaining lease term is approximately 18 years and

Arise AB (publ) has successfully issued green senior unsecured bonds of EUR 50,000,000

Arise AB (publ) (the "Company") has successfully issued green senior unsecured bonds of an amount of EUR 50,000,000 under a framework of EUR 100,000,000. The bonds carry a floating interest rate of 3m EURIBOR + 525 basis points and are due in May 2026. The Company intends to list the bonds on Nasdaq Stockholm Sustainable Bond List. The net proceeds will be used in accordance with Arise's newly established Green Financing Framework, including financing of new renewable energy projects. DNB Markets acted as Sole Bookrunner and Sustainability Advisor, Setterwalls Advokatbyrå AB acted as

Sandvik to acquire mining part of Schenck Process Group

Sandvik has signed an agreement to acquire the mining related business of Schenck Process Group (SP Mining). SP Mining is one of the market leaders in screening, feeding and screening media solutions in the industry. The company will be reported in Stationary Crushing and Screening, a division in Sandvik Rock Processing Solutions (SRP). "I am pleased that we continue to execute on our shift to growth strategy by expanding our core offering in a profitable niche, as well as strengthening the aftermarket share within rock processing. This validates our strategy when forming the Sandvik

Caverion updates its strategy focusing on sustainable growth and its financial targets

Caverion Corporation Stock Exchange Release 9 May 2022 at 9.00 a.m. EESTCaverion updates its strategy focusing on sustainable growth and its financial targets Caverion’s Board of Directors has approved the company’s updated strategy and the updated financial targets for the next strategy period until the end of 2025. The updated strategy focuses on sustainable revenue growth, profitability improvement and investments to support building performance. The company will differentiate itself in the market by creating sustainable impact for every customer with the solutions it designs and

Notification of change in adjusted EBITDA reporting

Catena Media plc has implemented an update to how it evaluates share-based incentive schemes that will affect the reporting of adjusted EBITDA, one of the company’s key alternative performance measures. The change, designed to facilitate full and representative comparability over time, will be applied starting with the Q1 report 2022, to be published on 18 May. The company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortisation excluding any items affecting comparability. An accounting review has concluded that expenses, and reversals of expenses,

Diamyd Medical's principal owner transfers half of his holdings in Diamyd Medical to his children

Diamyd Medical announces that its principal owner Anders Essen-Möller has notified the Swedish Financial Supervisory Authority of the sale of 4,500,000 Diamyd Medical shares in the form of gifts. Essen-Möller’s five children each receive 400,000 Class A shares and 500,000 Class B shares.The transaction corresponds to approximately half of Essen-Möller's holdings, which after the transaction amount to 4,556,263 shares, of which 1,187,000 shares in an endowment policy. After the transaction, Essen-Möller's shareholding in Diamyd Medical corresponds to an equity interest of approximately 4.4%

Change in the Group Management Team of Exel Composites

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      9 MAY 2022 at 09:00 EETMikko Kettunen, Exel Composites Plc’s CFO and member of the Group Management Team, has decided to take up new responsibilities outside the company. Kettunen’s employment will end on 8 November 2022, at the latest. The company will immediately start the recruitment process to appoint a new CFO.   “Mikko has served as Exel Composites' CFO since 2015 and has had a key role in the development of the company and in the implementation of our growth strategy. I warmly thank Mikko for his valuable contribution to Exel

GiG signs sportsbook & platform partnership with Full Games SA in Angola

Gaming Innovation Group Inc. (GiG) has signed an agreement with an Angolan operator, Full Games SA, for the provision of full Sportsbook and Player Account Management (PAM) services in the newly regulated market of Angola.  This is the first agreement that combines the offering from both GiG and Sportnco Gaming SAS, immediately showing the power and synergies of combining both product and managed services offerings. The new agreement in Angola marks a significant milestone for GiG signifying a new market entry, its first into regulated African markets. Full Game SA is a joint venture

There are no items matching the current filter
There are no more items matching the current filter
Back to top